Supporting and Streamlining Clinical Research in Immunology, Inflammation, and Allergy
Immunologic, inflammatory, and allergic diseases cause a significant burden to patients. There is a high unmet need for treatment options due to the complexities involved, as well as shared physiologic pathways across multiple indications and end organs. Streamline assets with broad indication potential by partnering with Medpace, an experienced, full-service CRO who can provide customized medical expertise across multiple therapeutic areas, including expertise in rare diseases. Medpace has the medical leadership, trained staff, global trial experience, and site relationships to make your study a success.
Making the Complex Seamless® in Global Immunology and Inflammation Clinical Trials
Achieve quality results, meet deadlines, and maximize efficiencies by partnering with a full-service CRO that excels in designing and executing clinical research across a spectrum of immune-mediated inflammatory diseases (IMIDs). Medpace medical, operational, and regulatory expertise in immunology and inflammation spans multiple therapeutic areas and indications, including rheumatology, allergy, dermatology, oncology, gastroenterology, respiratory, and ophthalmology. This extensive expertise coupled with a consistent track record of success ensures the flexibility to adapt to the unique needs of each trial and overcome the complex challenges associated with immune-mediated inflammatory diseases.
The intersection of immune-mediated inflammatory diseases (IMIDs) is handled through the collaboration of our medical leadership and functional areas. Medpace accelerates clinical development by fully embedding medical leadership and a wide array of relevant therapeutic expertise, integrated across all functional areas into the clinical trial process. Clinical immunologists are embedded within the trial to offer additional oversight. This cross-therapeutic and cross-functional area collaboration allows for optimized trial communication and execution, and ultimately, expedited timelines.
“As a boarded Allergist/Immunologist, my role is to provide specialty expertise to trials by bridging clinical and trial experience in allergic and immunologic indications that cross therapeutic areas bound by common inflammatory pathways.”
Kelly Allred Metz, MD
Medical Director, Medical Department, Medpace
The Medpace Advantage for Immune-Mediated Inflammatory Disease Trials
As a global CRO with a cross-functional collaborative model and extensive experience, our team can support your clinical development through:
Providing comprehensive support via our dedicated global regulatory submissions and global regulatory affairs teams
Strategic guidance from our dedicated, in-house patient recruitment and retention teams who are experienced in recruiting patient populations, including clinical trials in rare diseases, to accelerate patient enrollment
Strong, long-term relationships with investigators, experienced sites, networks, and key opinion leaders (KOLs) help facilitate strategic site selection, start-up, and recruitment efforts
Broad expertise across indications, including but not limited to: Amyloidosis, Atopic Dermatitis, Allergic Conjunctivitis, Allergic Rhinitis, Atopic Dermatitis, Cystic Fibrosis, Asthma/COPD, Celiac Disease, Crohn’s Disease, Chronic Rhinosinusitis with Nasal Polyps, Chronic Spontaneous Urticaria, Hereditary Angioedema, Inflammatory Bowel Disease, Eosinophilic Esophagitis, Mastocytosis, Psoriasis, Lupus, Systemic Sclerosis, Interstitial Lung Disease, IgG4-Related Disease, Sarcoidosis, Alpha-1 Antitrypsin Deficiency, and Hidradenitis Suppurativa
Integrated Services
Streamline complex immunology and inflamation clinical trials with a full-service, single-vendor outsourcing strategy. Our comprehensive CRO services are supported by our wholly-owned Central Laboratories, Bioanalytical Lab, Imaging and ECG Core Lab, and Phase I Unit, as well as a ClinTrak®, a Clinical Trial Management System that ties all study data together in a single platform.
Central Laboratories
Medpace Central Labs provide consistency in methods and instrumentation across wholly-owned and purpose-built laboratories located in the US, Europe, China and Singapore. We offer safety testing as well as a wide range of inflammation and immunology-related biomarker assays, and can quickly establish and validate novel assays as needed. The team of hands-on laboratory PhD scientists are actively engaged with your study team throughout the entire clinical development process and collaborate with laboratory technologists and the project management team to seamlessly execute your trial.
Imaging Core Lab
Medpace Core Lab provides comprehensive central imaging services including site assessment, instrument/site qualification, and training and expert evaluation. Medpace delivers collaboration, training, and resource planning around the globe with consultation on imaging biomarker strategy for clinical development plans across immunology. Our imaging and clinical trial experience ensures that imaging components are seamlessly integrated into the complex structure of the overall trial.
Learn more about our Integrated Approach to Global Clinical Research
